Recent reports have found that the posthatch chicken retina has the capacity for neuronal regeneration. The purpose of this study was to test whether the types of cells destroyed by neurotoxic lesions influence the types of cells that are regenerated, and whether exogenous growth factors stimulate neural regeneration in the chicken retina. N-methyl-D-aspartate (NMDA) was used to destroy amacrine and bipolar cells; kainate was used to destroy bipolar, amacrine, and ganglion cells; colchicine was used to selectively destroy ganglion cells. Following toxin-induced damage, bromo-deoxyuridine was used to label proliferating cells. In some animals, growth factors were injected into the vitreous chamber of the eye. We found that the proliferation of cells within the retina was stimulated by toxin-induced cell loss, and by insulin and FGF2. After either kainate-or colchicine-induced retinal damage, some of the newly generated cells expressed markers and had the morphology of ganglion cells. The combination of insulin and FGF2 stimulated the regeneration of ganglion cells in kainate-and colchicine-treated retinas. We conclude that exogenous growth factors can be used to stimulate neural regeneration in the retina. We propose that the type of neuron destroyed in the retina may allow or promote the regeneration of that neuronal type.
INTRODUCTION
The discovery of neural stem cells in the adult central nervous system has implied that neural regeneration may be possible in birds and mammals. Several recent in vivo studies have demonstrated that under certain circumstances there is limited regeneration of neurons in the cortex of mice (Magavi et al., 2000) , vocal nuclei of songbirds (Scharff et al., 2000) , and retina of chickens (Fischer and Reh, 2001) . While the numbers of newly generated neurons that are produced in response to damage are few, these studies provide hope that regenerative mechanisms might somehow be enhanced to increase the replacement of lost neurons. We have recently found that the combination of insulin and FGF2 injected into the vitreous chamber of the eye activates a neurogenic program in mature Mü ller glia of the retina (Fischer et al., 2002b) . It is possible that these growth factors might stimulate neural regeneration when applied to damaged retinas. One purpose of this study was to test whether insulin and FGF2 stimulate the regeneration of neurons in toxin-damaged retinas.
We have recently demonstrated that Mü ller glia in the chick retina are a potential source of neural regeneration (Fischer and Reh, 2001) . In response to NMDA-induced excitotoxic damage, numerous Mü ller glia dedifferentiate, re-enter the cell-cycle, and express proteins found in embryonic retinal progenitors. The majority of cells generated by proliferating Mü ller glia remain as undifferentiated progenitor-like cells, while some differentiate into Mü ller glia and a few differentiate into amacrine or bipolar neurons. We found no evidence that photoreceptors or ganglion cells were regenerated following NMDA-induced excitotoxicity. It is possible that the types of neurons produced by Mü ller glia-derived progenitors are influenced by the types of cells that are destroyed, since NMDA destroys primarily amacrine and bipolar neurons, while photoreceptor and ganglion cells survive (Tung et al., 1990; Fischer et al., 1998) . For example, while projection neurons in the cortex of adult rodents are not normally produced, selective destruction of projection neurons induces the regeneration of this cell type (Magavi et al., 2000) . In addition, the destruction of dopaminergic amacrine cells stimulates the selec-tive regeneration of this cell type in the larval frog retina (Reh and Tully, 1986) . To test whether the projection neurons of the retina could be regenerated, we selectively destroyed ganglion cells by using colchicine or by inducing more general damage that included the destruction of ganglion cells by using kainic acid (KA). KA is a potent neurotoxin in the chick retina, destroying primarily bipolar, amacrine, and ganglion cells (Ingham and Morgan, 1983; Dvorak and Morgan, 1983; Ehrlich et al., 1987) . By comparison, when applied on the day of hatching, colchicine selectively destroys about 90% of ganglion cells (Morgan, 1981; and nearly all dopamine-and glucagon-containing amacrine cells .
Here, we present data demonstrating that ganglion cells are regenerated in retinas where ganglion cells have been destroyed. Numbers of newly generated ganglion cells were not increased by insulin or FGF2 alone, but were increased when these factors were co-applied. These newly generated ganglion cells may have been produced by Mü ller gliaderived progenitors.
MATERIALS AND METHODS

Animals
The use of animals in these experiments was in accordance with the guidelines established by the National Institutes of Health and the University of Washington. Newly hatched leghorn chickens (Gallus gallus domesticus) were obtained from HandN Highline International (Seattle, WA) and kept on a cycle of 16 h light, 8 h dark (lights on at 6:00 a.m.). Chicks were housed in clear Nalgene cages at about 25°C. Chicks received water and Purina chick starter ad libitum.
Injections
Chicks were anesthetized and injected as described elsewhere (Fischer et al., 1998 Fischer and Reh, 2000) . To destroy retinal cells, we injected 200 nmol (42.6 g) of KA or 0.5 nmol (0.2 g) of colchicine in 20 l of sterile saline into the left eye on the day of hatching, postnatal day 0 (P0). Growth factors were injected every second day for 10 days starting at P5. We injected insulin (2 g/dose) or FGF2 (100 ng/dose), or a combination of these factors, in 20 l sterile saline added with 2 g BrdU and 0.1 mg/ml bovine serum albumin as carrier. All drugs were obtained from Sigma, and all growth factors were obtained from R&D Systems.
Fixation, Sectioning, Whole Mounts, and Immunocytochemistry
Retinas were dissected, fixed, sectioned, and immunolabeled as described elsewhere (Fischer et al., 1998 Fischer and Reh 2000) . For whole-mounted retinas, we following procedures described elsewhere (Fischer et al., 2002a) .
Working dilutions and sources of antibodies used in this study included: mouse anti-BrdU at 1:50 (Developmental Studies Hybridoma Bank), rat anti-BrdU at 1:80 (Accurate Chemicals), mouse anti-neurofilament at 1:2000 (RMO270; Zymed), rabbit anti-Brn3.0 at 1:1000 (Dr. E. Turner, University of California San Diego), mouse anti-Hu at 1:200 (Monoclonal Antibody Facility, University of Oregon), rabbit anti-calretinin at 1:1000 (Swant, Bellinzona, Switzerland), rabbit anti-visinin at 1:5000 (Dr. R.S. Polans, Dow Neurological Institute, Portland, OR), and rabbit anti-protein kinase C at 1:1000 (Research Diagnostics Inc.). Secondary antibodies included goat anti-rabbit Alexa568, goat anti-mouse Alexa568, and goat anti-rat Alexa488 (Molecular Probes Inc., Eugene, OR) diluted to 1:500 in PBS plus 0.3% Triton X-100.
Histology
Toluidine blue staining was done as described elsewhere (Fischer et al., 1998 .
Photography, Measurements, Cell Counts, and Statistical Analysis
Photomicrographs were taken by using a Ziess Axioplan II microscope equipped with epifluorescence, FITC, and rhodamine filter combinations, and a Spot Slider-RT digital camera (Diagnostic Inc.). The data and confocal images in Fig. 3 were obtained by using a Ziess Pascal LSM. Images were optimized for color, brightness, and contrast, and double-labeled images overlaid by using Adobe Photoshop 5.5. Montage figures were made by overlaying the clearly focused portions of images from two or more fields of view. Cell counts were made on at least four whole mounts from different animals, and means and standard errors calculated on data sets from at least four individuals. Data from treated and control eyes were compared statistically with the appropriate Student's t test (StatView for Macintosh).
RESULTS
NMDA-, colchicine-, and KA-induced damage have been well characterized in central regions of the chick retina (Ingham and Morgan, 1983; Dvorak and Morgan, 1983; Ehrlich et al., 1987; Morgan, 1981; Fischer et al., 1998, 1999). However, the extent of damage in peripheral regions of the retina (Ͼ45 o eccentricity) has not been described. Accordingly, we sought to characterize the loss of cells in peripheral regions of the retina that results from intraocular applications of NMDA, colchicine, or KA.
We observed the loss of retinal cells in vertical sections of the retina that were stained with toluidine blue. Consistent with previous reports, NMDA, colchicine, and KA induced a loss of thickness of the inner retinal layers (Figs. 1a-1d) (Morgan, 1981; . The loss of retinal thickness was greatest for KA-treatment, compared with that observed with either NMDA or colchicine treatment . These data suggest that KA destroyed more cells than NMDA or colchicine.
To assay the loss of ganglion cells, we labeled retinal whole mounts with antibodies to neurofilament. In salinetreated eyes, we observed that the density of neurofilamentpositive axons in the NFL was not uniform across all regions of the retina. For example, the density of axons in the NFL was less in peripheral regions of the retina ( To determine the extent of ganglion cell loss following treatment with different neurotoxins, we made cell counts from whole-mount preparations. Consistent with previous reports (Chen and Naito, 1999) , we found about 10,000 ganglion cells per mm 2 in central regions of the retina, and about 4,000 ganglion cells per mm 2 in dorsal peripheral regions of the retina (Fig. 1m) . NMDA treatment did not significantly affect the number of ganglion cells in central and peripheral regions of the retina (Fig. 1m) . By contrast, colchicine and KA caused massive losses of ganglion cells in both central and peripheral regions of the retina. In comparison, fewer ganglion cells survived exposure to KA compared with numbers of ganglion cells that survive exposure to colchicine (Fig. 1m) 
Toxin-Induced Cell Loss and Exogenous Growth Factors Stimulate the Proliferation of Cells in the Retina
We have shown previously that NMDA-induced retinal damage causes Mü ller glia to go through only one round of division, entering S-phase 2 days after the toxin was applied (Fischer and Reh, 2001 ). To assay cell proliferation in retinas treated with colchicine and KA, we injected the thymidine analogue 5-bromo-2-deoxyuridine along with growth factors into the vitreous chamber. Five injections were made every other day starting at P5, and retinas were processed for immunocytochemistry at P21, 5 days after the final injection. In saline-treated eyes that received injections of BrdU in saline, we found a few BrdU-labeled cells (Figs. 2a and 2i) . Most of these cells were in the NFL and GCL (data not shown). In toxin-damaged retinas that received injections of BrdU in saline, we found significantly more BrdU-labeled cells than in undamaged retinas (Figs. 2b  and 2i ). Undamaged and toxin-treated retinas that received injections of FGF2 alone did not contain increased numbers of BrdU-labeled cells (Figs. 2c, 2d, and 2i) . In undamaged retinas that were injected with insulin alone, we found increased numbers of BrdU-labeled cells compared with numbers observed in undamaged, saline-treated eyes (Figs.  2e and 2i) . The number of BrdU-labeled cells in retinas treated with insulin alone was increased in toxin-damaged eyes compared with numbers observed in undamaged, insulin-treated eyes (Figs. 2f and 2i) . The greatest numbers of BrdU-labeled cells were observed in retinas treated with both insulin and FGF2, regardless of toxin treatment (Figs.  2g-2i) .
To determine whether toxin-induced damage or injections of growth factors influence where proliferating cells accumulate within the retina, we used laser-scanning confocal microscopy to quantify the distribution of BrdUlabeled cells within the cell layers of the retina. In retinas damaged by NMDA or KA and treated with BrdU in saline, the number of BrdU-labeled cells was not significantly different between toxin treatments, with most of the cells in the GCL/NFL, few in the INL, and none in the ONL (Figs. 3a, 3b, 3e, and 3f) . By contrast, in undamaged retinas that received doses of insulin and FGF2, we found increased numbers of BrdU-labeled cells; most of these cells were in the INL and some were found in the ONL (Figs. 3c, 3e , and 3f). Numbers of BrdU-labeled cells in the GCL/NFL, INL, or ONL were not significantly different in retinas damaged by NMDA and treated with insulin and FGF2 compared with numbers observed in undamaged retinas treated with insulin and FGF2 (Figs. 3c, 3e, and 3f) . In retinas damaged by KA and treated with insulin and FGF2, increased numbers of BrdU-labeled cells were in the GCL and decreased numbers in the ONL, compared with numbers of BrdU-labeled cells observed in undamaged and NMDA-damaged retinas treated with insulin and FGF2 (Figs. 3c-3f ). This finding suggests that the destruction of ganglion cells by KA and subsequent application of insulin and FGF2 increases the recruitment of BrdU-labeled cells to the GCL.
Toxin-Induced Cell Loss and Insulin Plus FGF2 Stimulate the Regeneration of Ganglion Cells
To assay for the production of ganglion cells, we used retinal whole-mount preparations that were immunolabeled for BrdU and neurofilament. We did not observe any BrdU/neurofilament-labeled cells in NMDA-treated retinas, where there was little or no loss of ganglion cells (Fig.  4a) . In retinas treated with colchicine or KA, we found BrdU/neurofilament-positive cells within the retina. These cells were found primarily in peripheral regions of the retina, within 4 mm from the retinal margin. Most of these cells (78.5%) were found in dorsal regions of the retina, where losses of ganglion cells were greatest. Regardless of the type of toxin treatment, the abundance of newly generated neurofilament-immunoreactive cells within the retina was not increased significantly by treatment with insulin alone or FGF2 alone (Fig. 4a) . By comparison, coinjection of insulin and FGF2 significantly (P Ͻ 0.005) increased the number of BrdU/neurofilament-labeled cells in dorsal regions of retinas damaged by colchicine or KA (Fig. 4a) . However, we never observed BrdU/neurofilament-labeled cells in NMDA-treated retinas that were treated with the combination of insulin and FGF2 (Fig. 4a) . Regardless of growth factor treatment, there were significantly (P Ͻ 0.005) more BrdU/neurofilament-labeled cells in retinas treated with KA compared with the numbers of these cells in retinas treated with NMDA or colchicine (Fig. 4a) .
Cells labeled for BrdU and neurofilament had a variety of morphologies. Some BrdU/neurofilament-labeled cells formed few local processes lacking well-defined dendritic arbors or axons (Figs. 4b-4d ). These cells may have been in early stages of differentiation. Other cells appeared to be in an intermediate stage of differentiation with numerous short dendrite-like processes (Ͻ30 m in length; Figs. 4e-4g). Most BrdU/neurofilament-positive cells were relatively small, with somata about 8 m in diameter, and formed numerous peripheral processes (Figs. 4h-4j) . A few BrdU/neurofilament-positive cells were large, with somata up to 14 m in diameter, and formed extensive peripheral processes (Figs. 4k-4m ).
In the chicken retina, neurofilament is express by ganglion cells and efferent target cells (Bennett and DiLullo, 1985a,b; Pittack et al., 1997; . To further investigate the phenotype of BrdU/neurofilamentlabeled cells, we probed retinal whole mounts for BrdU-and Brn3.0-immunoreactivity. Brn3.0 is a homeotic transcription factor that contains a POU domain and is known to be required for the differentiation and survival of retinal ganglion cells (Xiang et al., 1993; Gan et al., 1996; Liu et al., 2001 ). In the postnatal chicken retina, Brn3.0 is expressed by only orthotopic ganglion cells (Fischer et al., 2002a) . In whole-mount preparations of undamaged retina, we found numerous Brn3.0-immunoreactive cells in the GCL (Fig.  5a ). In eyes that were damaged by colchicine or KA and received injections of insulin and FGF2, we found cells that were labeled for BrdU and Brn3.0 (Figs. 5b-5g ). This suggests that many of the newly generated neurofilamentlabeled cells were ganglion cells. These cells were observed up to 4 mm away from the retinal margin, toward central regions of the retina.
To confirm findings in retinal whole mounts, we probed for newly generated neurons in retinal sections. In both normal and toxin-treated retinas, neurofilamentimmunoreactivity is weak in the somata of ganglion cells and is difficult to clearly localize. Therefore, we probed for newly generated neurons by using antibodies to Hu, an RNA-binding protein related to ELAV proteins of Drosophila (Marusich et al., 1994; Barami et al., 1995) . In the postnatal chick retina, Hu is expressed by most, if not all, amacrine and ganglion cells Reh, 2000, 2001) . In retinas damaged by colchicine or KA, we found Huimmunolabeled cells that were positive for BrdU, regardless of growth factor injections. Most of these cells (57 of 84 cells counted) were found near the GCL (Figs. 6a-6c) , while a few of these cells were found in the INL (20/84; Figs. 6d-6f). Occasionally, we observed Hu/BrdU-labeled cells in the ONL (7/84; Figs. 6g-6i ), where this cell type normally is not situated, suggesting that the distribution of newly generated neurons in toxin-damaged retinas may be abnormal. By comparison, we never observed neurofilament/ BrdU-positive cells in retinal layers other than the GCL. Hu/BrdU-positive cells were found up to 4 mm from the peripheral edge of the retina.
We found many BrdU-labeled cells in the ONL and distal INL, where the cell bodies of photoreceptor, horizontal and bipolar cells, respectively, are known to reside. However, we did not find any BrdU-labeled cells that were colabeled with the photoreceptor marker visinin, the horizontal cell marker calretinin, or the bipolar cell marker protein kinase C.
DISCUSSION
Here, we report that neural regeneration in the chicken retina can include the regeneration of ganglion cells. This cell type was regenerated only in retinas where ganglion cells were destroyed and in regions of retina with significant losses of ganglion cells (Fig. 7) . We also found that the combination of insulin and FGF2 stimulated the regeneration of ganglion cells, while these factors applied separately had no effect on the number of regenerated neurons.
Some of the BrdU/neurofilament-positive cells in toxintreated retinas were likely to be newly generated ganglion cells. In normal chicken retinas, neurofilament is expressed selectively by ganglion cells (Torelli et al., 1989; Bradshaw et al., 1995; Pittack et al., 1997) and efferent target cells . However, neurofilament is expressed transiently by Mü ller glia in following toxininduced retinal damage (Fischer and Reh, 2001) or following intraocular injections of exogenous insulin and FGF2 (Fischer and Reh, unpublished observation). In both of these cases, the expression of neurofilament lasted only a few days and returned to normal by 4 days after treatment. In the current study, we probed for the expression of neurofilament at least 5 days after the final dose of growth factor. Therefore, levels of neurofilament expression should have fallen below detectable levels in Mü ller glia by the time we made our observations. Further, none of the BrdU/ neurofilament-positive cells had the morphology of Mü ller glia; instead, these cells had neuronal morphology (see Fig.  4 ). Further, we detected BrdU in the nuclei of cells that expressed the ganglion cell-specific markers Brn3.0 and Hu, confirming that at least some of the newly generated cells in retinas damaged by colchicine or KA are ganglion cells.
In addition to the neurofilament/BrdU-labeled cells, we observed many cells labeled with BrdU alone in saline-and insulin-treated retinas in the GCL or NFL. These cells may have been oligodendrocytes. In the chick retina, although astrocytes are confined to the optice nerve head (Schuck et al., 2000) , oligodendrocytes migrate into the retina from the optic nerve (Huxlin et al., 1992; Ono et al., 1998) and reside in the GCL and NFL (Villegas, 1960; Nakazawa et al., 1993; Ono et al., 1998) . Oligodendrocytes have been shown to proliferate within the chick retina at about E14 (Nakazawa et al., 1993) . It is possible that insulin and FGF2 stimulated the proliferation of oligodendrocytes in the postnatal chick retina, and many of the BrdU-labeled cells that we observed in the GCL and NFL were oligodendrocytes.
One potential source for the regenerated ganglion cells is the Mü ller glia. We have recently reported that Mü ller glia in the postnatal chicken retina are a source of neural progenitors (Fischer and Reh, 2001) . We demonstrated that in response to sufficient damage elicited by NMDA, numerous Mü ller glia re-enter the cell cycle, dedifferentiate, express genes common to embryonic retinal progenitors, and produce some amacrine and bipolar neurons and some glia. In addition, we have recently reported that intraocular injections of insulin and FGF2 stimulated the production of new neurons from mature, postmitotic Mü ller glia in the absence of retinal damage (Fischer et al., 2002b) . The combination of insulin and FGF2 was required to stimulate the proliferation and transdifferentiation of Mü ller glia, while insulin alone or FGF2 alone had no effect. Similarly, in the present study, we found that the combination of insulin and FGF2 increased the number of newly generated ganglion cells, while insulin alone or FGF2 alone had no effect. Taken together, these findings suggest that injections of insulin and FGF2-stimulated Mü ller glia to regenerate ganglion cells in toxin-damaged retinas.
An alternative source of the regenerated ganglion cells is the progenitors at the retinal margin. The progeny of these cells could have migrated laterally into the retina and, subsequently, differentiated into ganglion cells. In this study, we observed newly generated neurons up to 4 mm away from the retinal margin (Fig. 6) . Given that the first application of BrdU was about 2 weeks prior to observation, ample time elapsed for a migrating cell to travel 4 mm. However, long-distance lateral migration of neuroblastic cells within the retina has not been previously observed. A final possibility is that regenerated ganglion cells were derived from quiescent stem cells that are seed within the retina. For example, a population of quiescent stem cells has been described in the adult teleost retina (Julian et al., 1998; Otteson et al., 2001) . Quiescent neural stem cells may also exist in the postnatal chicken retina, but there is currently no evidence to support this hypothesis.
The mechanisms underlying the synergistic activity of insulin and FGF2 remain uncertain. We report here that insulin or FGF2 alone did not increase numbers of regenerated ganglion cells, while the combination of these two factors had a significant effect. Insulin and FGF have been shown to act in synergy in a variety of biological systems (Chamberlain et al., 1991; Werther et al., 1993; Frodin and Gammeltoft, 1994; Reape et al., 1996; Liu et al., 1996) . We have reported elsewhere that in undamaged retinas the combination of insulin and FGF2 stimulates the production of ganglion cells by progenitors at the retinal margin (Fischer et al., 2002a) and activates a neurogenic program in postmitotic Mü ller glia in the absence of retinal damage (Fischer et al., 2002b) . Receptors for FGF2 and insulin/IGF are likely to be coexpressed by Mü ller glia. Receptors for FGF2 and insulin/IGF are expressed throughout the chick retina (Waldbillig et al., 1991; de la Rosa et al., 1994; Rohrer et al., 1997; unpublished observations) . Activation of receptors for FGFs or insulin results in the activation of a MAP kinase signaling cascade (Boulton et al., 1991 ; reviewed by Szebenyi and Fallon, 1999) . In the retina, activated MAP kinase signaling is commonly observed in Mü ller glia (Peng et al., 1998; Wahlin et al., 2000; Kinkl et al., 2001; Takeda et al., 2002) . It is possible that the cumulative activation of the MAP kinase pathway by both insulin and FGF2 is required to activate a neurogenic program in Mü ller glia in the chick retina, and thus increase the number of regenerated ganglion cells in toxin-damaged retinas.
Our findings suggest that the loss of ganglion cells somehow allows or promotes their regeneration. Alternatively, the types of neurons that survive toxin treatment in the chick retina may regulate the types of cells that are regenerated. We have reported previously that bipolar and amacrine neurons are regenerated in retina damaged by a single toxic dose of NMDA (Fischer and Reh, 2001 ). In NMDA-treated retinas, we did not observe the regeneration of any cells in the GCL, including displaced cholinergic amacrine cells (Fischer and Reh, 2001) . NMDA destroys primarily amacrine and bipolar cells, while leaving photoreceptor and ganglion cells intact (Tung et al., 1990; Fischer et al., 1998) . By comparison, we observed regenerated ganglion cells in retinas that were damaged by colchicine or KA. We found that these toxins destroyed numerous ganglion cells, consistent with the reports of others (Ingham and Morgan, 1983; Dvorak and Morgan, 1983; Morgan, 1981; . It is possible that the destruction of ganglion cells allows some of the progeny of proliferating Mü ller glia to differentiate as new ganglion cells. Consistent with this hypothesis, we observed increased numbers of regenerated neurons where more cell loss had occurred. For example, more ganglion cells were regenerated in KAtreated retinas compared with colchicine-treated retinas, and KA caused greater ganglion cell loss than colchicine. In addition, the regenerative response was greater in dorsal retinal regions near the site of toxin injection. Consistent with these findings, the selective destruction of dopaminergic amacrine cells in the larval tadpole retina results in the selective regeneration of this cell type at the retinal margin (Reh and Tully, 1986) , and KA-induced retinal cell loss causes in an increase in the production of inner retinal neurons from stem cells at the retinal margin (Reh, 1987) . Further, Magavi et al. (2000) reported that selective ablation of projection neurons in the cortex of adult mice selectively stimulated the regeneration of this cell type. It is possible   FIG. 6 . Damage to the retina results in the regeneration of Hu-expressing retinal neurons. Vertical retinal sections were double-labeled for BrdU (in green) and Hu (in red). Retinas were obtained from eyes that were treated with colchicine on the day of hatching, and received doses of insulin plus FGF2 every second day for 10 days starting at P3. Retinas were processed for immunocytochemistry at P16. Hu/BrdU-labeled cells were found in GCL (a-c), INL (d-f), or ONL (g-i). The calibration bar (50 m) in (f) applies to (d-f), and the bar in (i) applies to (a-c) and (g-i). Abbreviations: ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer.
that destroying a particular cell type allows for the replacement of that cell type. This process may occur via a feedback mechanism (Hinds and Hinds, 1974; Reh, 1987) . For example, the production and/or survival of ganglion cells may be regulated by a feedback mechanism during embryonic development (Waid and McLoon, 1998; Gonzalez-Hoyuela et al., 2000) .
We conclude that the types of cells regenerated in the retina are influenced by the types of cells that are destroyed. We further conclude that the numbers of regenerated neurons can be increased by exogenous growth factors. We propose that exogenous growth factors may used to stimulate glial cells to generate neurons in the retina and other regions of the central nervous system.
